Innocan Pharma Corporation: Innocan Pharma Announces the Inauguration of Its Drug Development Lab at Biohouse in the Hadassah Medical Center in Jerusalem

Herzliya, Israel and Calgary, Alberta--(Newsfile Corp. - January 17, 2022) - Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTCQB: INNPF) (the "Company" or "Innocan") is pleased to announce that it

Related Keywords

Jerusalem ,Israel General ,Israel ,Herzliya ,Tel Aviv ,Canada ,Hebrew University ,Yerushalayim ,Canadian ,Iris Bincovich ,Chezy Barenholz ,Innocan Pharma ,Company Or Innocan ,Innocan Pharma Corporation ,Platform Technology ,Liposome Research Department ,Lytham Partners ,Biohouse Labs At Hadassah Medical Center ,Hebrew University Of Jerusalem ,Alberta Newsfile Corp ,Tel Aviv University ,Pharma Corporation ,Biohouse Labs ,Hadassah Medical Center ,License Agreement ,Professor Chezy Barenholz ,Professor Barenholz ,Innocan Israel ,Vice President ,Innocan ,Dharma ,Corporation ,Nnounces ,Inauguration ,Drug ,Development ,Iohouse ,Hadassah ,Medical ,Center ,